There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.

Biologics Quality Control: The Growing Need for Accessible Proteomics

The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.

Emerging Therapies Drive Analytical Advancements

Effective analytics will eliminate failures, deviations, and non-conformances.

 Analyzing Exabytes

Topic

Articles

Roche Details Restructuring Plan; Sigma-Aldrich Names Successors after CEO's Death; and More.

Week of Nov. 15, 2010: Company and People Notes: Roche Details Restructuring Plan; Sigma-Aldrich Names Successors after CEO's Death; and More.

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

The biotechnology company Biogen Idec (Weston, MA) announced last week a major restructuring program that will refocus the company's research and development (R&D) programs, consolidate facilities, and reduce its workforce.

Biogen Idec Announces Restructuring Program

PQRI and FDA present Process Drift Workshop, and More.

Regulatory Roundup: PQRI and FDA present Process Drift Workshop, and More.

The US Food and Drug Administration's Puerto Rico district office "may be having difficulty exercising oversight on the numerous pharmaceutical manufacturing facilities on the island," according to Rep. Edolphus Towns (D-NY), chair of the US House of Representatives Committee on Oversight and Government Reform.

Lawmakers Question the Activities of FDA's Puerto Rico Office

Eli Lilly Acquires Avid Radiopharmaceuticals; EMA Recruiting New Director; and More

Week of Nov. 8, 2010: Company and People Notes: Eli Lilly Acquires Avid Radiopharmaceuticals; EMA Recruiting New Director; and More.

Stephanie Sutton was an assistant editor at Pharmaceutical Technology Europe.

The market for orally disintegrating and fast dissolving tablets could exceed revenues of $13 billion by 2015 based on upward global growth trends, according to a report from Technology Catalysts International, a technology transfer and business consulting firm based in Virginia.

ODT Market to Exceed $13 Billion by 2015

Sanofi-aventis (Paris) has asked Genzyme to stand aside and let the shareholders decide on whether an acquisition should take place.

Sanofi and Genzyme Still at Odds Over Acquisition

Angie Drakulich was editorial director of Pharmaceutical Technology.

The European Medicines Agency published a draft list of questions and answers on postapproval change-management protocols last week.

EMA Issues Draft Principles on Postapproval Change Management

The growth in pharmaceutical outsourcing is creating a more complex and risky supply-chain environment, according to a report issued last week.

Industry Needs New Approach To Manage Growing Supply-Chain Complexity

sanofi acquires BMP Sunstone; DCAT Names President; and More.

Analytics

Biologics Quality Control: The Growing Need for Accessible Proteomics

Emerging Therapies Drive Analytical Advancements

Analyzing Exabytes